NASDAQ:OBLN Long Term Investor Notice: Investigation of Potential Wrongdoing at Obalon Therapeutics Inc
An investigation on behalf of current long-term investors in shares of Obalon Therapeutics Inc (NASDAQ:OBLN) concerning potential breaches of fiduciary duties by certain directors and officers of Obalon Therapeutics Inc was announced.
View full press release